[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100362992":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":10,"locations":19,"responsibleParty":40,"collaborators":7,"id":43,"slug":7,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":49,"minAge":7,"maxAge":7,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"First Affiliated Hospital of Fujian Medical University","OTHER",null,[9],{"type":6,"name":7,"description":7,"armGroupLabels":7,"otherNames":7},[11,16],{"name":12,"role":13,"phone":14,"phoneExt":7,"email":15},"Yi Lin, MD,PhD","CONTACT","+13615039153","wanjinchen75@fjmu.edu.cn",{"name":17,"role":13,"phone":18,"phoneExt":18,"email":15},"Wan-Jin Chen, MD,PhD","+1386061359",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":7,"country":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"First Affiliated Hospital Fujian Medical University","RECRUITING","Fuzhou","China",{"type":26,"coordinates":27},"Point",[28,29],119.30611,26.06139,{"lat":29,"lon":28},[32,34,37],{"name":33,"role":13,"phone":7,"phoneExt":7,"email":15},"Wan-Jian Chen, MD, PhD",{"name":35,"role":36,"phone":7,"phoneExt":7,"email":7},"Wan-Jin Chen","PRINCIPAL_INVESTIGATOR",{"name":38,"role":39,"phone":7,"phoneExt":7,"email":7},"Ning Wang","SUB_INVESTIGATOR",{"type":41,"investigatorFullName":35,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","The Vice-Director for the Department of Neurology","100362992",false,"NCT04006418","A Registered Cohort Study on Spastic Paraplegia","Inclusion Criteria:\n\n* Patients with the clinical diagnosis of spastic paraplegia\n* Clinical diagnosis of patients with spastic paraplegia\n* Unrelated healthy controls\n\nExclusion Criteria:\n\n* Decline to participate.\n* There are serious interferences with individual participation and adherence to the research protocol, including but not limited to neurological, psychological, and\u002For medical conditions.",true,"ALL",{"count":51,"type":52},500,"ESTIMATED","20 Years","OBSERVATIONAL","The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias(HSP) and related disorders in a prospective multicenter natural history study, to assess the clinical, genetic and epigenetic features of patients with Spastic Paraplegias to optimize clinicalmanagement..",[57],"Spastic Paraplegia","2022-01-16",{"date":60,"type":61},"2022-01-19","ACTUAL",{"date":63,"type":61},"2019-07-01",{"date":65,"type":52},"2049-12",{"name":35,"class":6},1]